These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 35747072)

  • 1. Analysis of the trend in community prescribing of RAAS inhibitors during the COVID-19 pandemic.
    Guscoth L; Hodgson S
    Br J Cardiol; 2021; 28(4):44. PubMed ID: 35747072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
    Son M; Seo J; Yang S
    Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic.
    Gressens SB; Leftheriotis G; Dussaule JC; Flamant M; Levy BI; Vidal-Petiot E
    Front Physiol; 2021; 12():624052. PubMed ID: 33692701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
    de Abajo FJ; Rodríguez-Martín S; Lerma V; Mejía-Abril G; Aguilar M; García-Luque A; Laredo L; Laosa O; Centeno-Soto GA; Ángeles Gálvez M; Puerro M; González-Rojano E; Pedraza L; de Pablo I; Abad-Santos F; Rodríguez-Mañas L; Gil M; Tobías A; Rodríguez-Miguel A; Rodríguez-Puyol D;
    Lancet; 2020 May; 395(10238):1705-1714. PubMed ID: 32416785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review.
    Iheanacho CO; Odili VU; Eze UIH
    Futur J Pharm Sci; 2021; 7(1):73. PubMed ID: 33778087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study.
    Jung SY; Choi JC; You SH; Kim WY
    Clin Infect Dis; 2020 Nov; 71(16):2121-2128. PubMed ID: 32442285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019.
    Coto E; Avanzas P; Gómez J
    Eur Cardiol; 2021 Feb; 16():e07. PubMed ID: 33737961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renin-angiotensin-aldosterone system : brief history and questions related to the COVID-19 pandemic].
    Valdes-Socin H; Jouret F; Vroonen L; Scheen AJ; Lancellotti P
    Rev Med Liege; 2020 Sup; 75(S1):123-129. PubMed ID: 33211434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19.
    Loader J; Lampa E; Gustafsson S; Cars T; Sundström J
    J Am Heart Assoc; 2021 Aug; 10(15):e021154. PubMed ID: 34320843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients.
    Baral R; White M; Vassiliou VS
    Curr Atheroscler Rep; 2020 Aug; 22(10):61. PubMed ID: 32830286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2.
    Young MJ; Clyne CD; Chapman KE
    J Endocrinol; 2020 Nov; 247(2):R45-R62. PubMed ID: 32966970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension.
    Chen R; Yang J; Gao X; Ding X; Yang Y; Shen Y; He C; Xiang H; Ke J; Yuan F; Cheng R; Lv H; Li P; Zhang L; Liu C; Tan H; Huang L
    J Clin Hypertens (Greenwich); 2020 Nov; 22(11):1974-1983. PubMed ID: 33006442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and RAAS inhibitors: is there a final conclusion?
    Talebi-Taher M; Najafi MH; Behzad S
    Iran J Microbiol; 2021 Dec; 13(6):728-736. PubMed ID: 35222849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
    Werner C; Pöss J; Böhm M
    Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis.
    Ssentongo AE; Ssentongo P; Heilbrunn ES; Lekoubou A; Du P; Liao D; Oh JS; Chinchilli VM
    Open Heart; 2020 Nov; 7(2):. PubMed ID: 33154144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
    Adin D; Atkins C; Domenig O; DeFrancesco T; Keene B; Tou S; Stern JA; Meurs KM
    J Vet Intern Med; 2020 Mar; 34(2):600-606. PubMed ID: 32112596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea.
    Park J; Lee SH; You SC; Kim J; Yang K
    PLoS One; 2021; 16(3):e0248058. PubMed ID: 33705440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
    Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
    Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
    Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
    J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.
    Pirola CJ; Sookoian S
    J Infect; 2020 Aug; 81(2):276-281. PubMed ID: 32474043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.